Larivin Pharma Private Limited
About Larivin Pharma Private Limited
Data last updated:
Larivin Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 04 July 2023.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U21001TN2023PTC161631. Its GSTIN is 33AAFCL4624D1ZX (Tamil Nadu).
The company has an authorised share capital of ₹1.26 Cr and a paid-up capital of ₹1.26 Cr. It is led by directors including Natesavalavan Monalisa and Saravanan Nambiyappan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.83 Cr. For the same year it recorded a net profit of ₹45.85 Lakh (net margin 3.6%) and EBITDA of ₹68 Lakh (EBITDA margin 5.3%).
As per MCA filings, the company has open charges of ₹4.18 Cr on record.
Company details
Contact details
Larivin Pharma Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressPlot No. 15, Natesan Nagar, Chennai, Tamil Nadu, India – 600095
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Larivin Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Larivin Pharma Private Limited, buy the company report.
Financials of Larivin Pharma Private Limited
FY 2024 filings availableLarivin Pharma Private Limited reported revenue of ₹12.83 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹68 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹45.85 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 5.3% |
| Net Profit Margin | 3.6% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Larivin Pharma Private Limited, buy the company report.
Board of directors of Larivin Pharma Private Limited
Larivin Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Natesavalavan Monalisa | Director | 14 May 2024 | 2 Years 5 Months | Current |
| Saravanan Nambiyappan Also directs: Larion Life Sciences Private Limited | Director | 04 Jul 2023 | 3 Years 4 Months | Current |
| Ramaiyan Natesavalavan Also directs: Larion Life Sciences Private Limited | Director | 04 Jul 2023 | 3 Years 4 Months | Current |
| Saravanan Haritha | Director | 04 Apr 2025 | 1 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2025 | 101217749 | Others | ₹20.23 Lakh | Open | |
| 23 Jan 2025 | 101071031 | Others | ₹20.61 Lakh | Open | |
| 05 Jul 2024 | 100963802 | Others | ₹3.77 Cr | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Larivin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Larivin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Larivin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCL4624D1ZX | Tamil Nadu | Active | 04 Jul 2023 |
To see the full GST registrations and return filing status of Larivin Pharma Private Limited, buy the company report.
Recent activity
Larivin Pharma Private Limited has 6 board changes on record since 2023: 5 appointments and 1 cessation. The latest: Kumaralingam Sujatha ceased to be Director on 05 Apr 2025.
Frequently asked questions
Larivin Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in paper and paper products, within the paper industry. It was incorporated on 04 July 2023 (3+ years old) and is registered under CIN U21001TN2023PTC161631.
Larivin Pharma has 4 current directors:
- Natesavalavan Monalisa - Director
- Saravanan Nambiyappan - Director
- Ramaiyan Natesavalavan - Director
- Saravanan Haritha - Director
The latest financial statements of Larivin Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Larivin Pharma is 33AAFCL4624D1ZX, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Larivin Pharma is U21001TN2023PTC161631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Larivin Pharma was incorporated on 04 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chennai.
Kumaralingam Sujatha ceased to be Director on 05 Apr 2025. Saravanan Haritha was appointed as Director on 04 Apr 2025. Kumaralingam Sujatha was appointed as Director on 14 May 2024. Larivin Pharma has 6 board changes on record in total.
The registered office of Larivin Pharma is at Plot No. 15, Natesan Nagar, Chennai, Tamil Nadu, India – 600095.
Larivin Pharma operates in the paper industry, in the paper and paper products segment.
Larivin Pharma has open charges of ₹4.18 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
